|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Intraoperative ERCP : 它在 laparoscopic 胆囊炎的时代有什么角色?显示文摘 In the treatment of patients with symptomatic cholelithiasis and choledocholithiasis (CBDS) detected during intraoperative cholangiography (IOC),or when the preoperative study of a patient at intermediate risk for CBDS cannot be completed due to the lack of imaging techniques required for confirmation,or if they are available and yield contradictory radiological and clinical results,patients can be treated using intraoperative endoscopic retrograde cholangiopancreatography (ERCP) during the laparoscopic treatment or postoperative ERCP if the IOC finds CBDS.The choice of treatment depends on the level of experience and availability of each option at each hospital.Intraoperative ERCP has the advantage of being a single-stage treatment and has a significant success rate,an easy learning curve,low morbidity involving a shorter hospital stay and lower costs than the two-stage treatments (postoperative and preoperative ERCP).Intraoperative ERCP is also a good salvage treatment when preoperative ERCP fails or when total laparoscopic management also fails. | Luis R Rábago Alejandro Ortega Inmaculada Chico David Collado Ana Olivares Jose Luis Castro Elvira Quintanilla | 2011 | World Journal of Gastrointestinal Endoscopy2011，3，12： | 13 |
| 2 | Western view of the management of gastroesophageal foreign bodies显示文摘The best modality for foreign body removal has beenthe subject of much controversy over the years.We have read with great interest the recent article by Souza Aguiar Municipal Hospital,Rio de Janeiro,Brazil,describing their experience with the management of esophageal foreign bodies in children.Non-endoscopic methods of removing foreign bodies(such as a Foley catheter guided or not by fluoroscopy)have been successfully used at this center.These methods could be an attractive option because of the following advantages:Shorter hospitalization time;easy to perform;no need for anesthesia;avoids esophagoscopy;and lower costs.However,the complications of these procedures can be severe and potentially fatal if not performed correctly,such as bronchoaspiration,perforation,and acute airway obstruction.In addition,it has some disadvantages,such as the inability to directly view the esophagus and the inability to always retrieve foreign bodies.Therefore,in Western countries clinical practice usually recommends endoscopic removal of foreign bodies under direct vision and with airway protection whenever possible. | Aurora Burgos Luis Rábago Paloma Triana | 2016 | World Journal of Gastrointestinal Endoscopy2016，8，9： | 3 |
| 3 | Ectopic papilla of Vater in the pylorus显示文摘The major papilla of Vater is usually located in the second portion of the duodenum, to the posterior medial wall. Sometimes the mouth of the biliary duct is located in other areas. Drainage of the common bile duct into the pylorus is extremely rare. A 73-year old man, with a history of duodenal ulcer, was admitted to hospital with the diagnosis of cholangitis. Dilatation of the extrahepatic biliary duct was observed by abdominal ultrasonography, and endoscopic retrograde cholangiopancreatography (ERCP) was performed. No area suggesting the presence of the papilla of Vater was found within the second duodenal portion. Finally the major papilla was located in the theoretical pyloric duct. Cholangiography was performed and choledocholithiasis was found in the biliary tree. The patient underwent dilatation of the papilla with a balloon tyre and removal of a 7 mm stone using a Dormia basket, which solved the problem without further complications. This anomaly increased the difficulty of performing therapeutic interventions during ERCP. This alteration in anatomy may increase the risk of complications during papillotomy, with a theoretically higher risk of perforation. Dilatation using a balloon was the chosen therapeutic technique both in our case and in the literature, due to its low rate of complications. | Iván Guerra Luis Ramón Rábago Fernando Bermejo Elvira Quintanilla Silvia García-Garzón | 2009 | World Journal of Gastroenterology2009，15，41： | 3 |
| 4 | Subcellular localization of Nm23/NDPK A and B isoforms:a reflection of their biological function显示文摘 | Bosnar MH Bago R Cetkovic H | 2009 | Mol Cell Biochem2009，329，12： | 1 |
| 5 | Applications of life cycle assessment to nature worksTM polylactide (PLA) production显示文摘 | Erwin T H Vink Karl R Rábago David A Glassner | 2003 | Polymer Degradation and Stability2003，80，： | 1 |
| 6 | The Potential for Cain Sequestration Through Rreforestation of Abandoned Tropical Agricultural and Pasture Lnds显示文摘 | Silver WL Ostertang R bago AE | 2000 | Restoration Ecology2000，，8： | 1 |
| 7 | Subcellular localization of Nm23/NDPK A and B isoforms:a reflection of their biological function显示文摘 | Bosnar MH Bago R Cetkovic H | 2009 | Mol Cell Biochem2009，329，12： | 1 |
| 8 | The BNP assay dose not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients 显示文摘 | Valle R Bago LE Canali C | 2006 | Eur Echocardiogr2006，7，1： | 1 |
| 9 | Subcellular localization of Nm23/NDPK A and B isoforms:a reflection of their biological function?显示文摘 | BOSNAR M H BAGO R CETKOVIC H | 2009 | Mol Cell Biochem2009，329，12： | 1 |
| 10 | Subcellular localization of A and B Nm23/NDPK subunits 显示文摘 | Bosnar M H Gunzburg de J Bago R | 2004 | Exp Cell Res2004，298，： | 1 |
| 11 | Single-stage treatment with intraoperative ERCP: management of patients with possible choledocholithiasis and gallbladder in situ in a non-tertiary Spanish hospital显示文摘 | Rábago LR Chico I Collado D | 2012 | Surg Endosc2012，26，4： | 1 |
| 12 | Applications of life cycle assessment to NatureWorks? polylactide (PLA) production显示文摘 | Erwin T.H. Vink Karl R. Rábago David A. Glassner Patrick R. Gruber | 2003 | Polymer Degradation and Stability2003，，3： | 1 |
| 13 | Subcellular localization of Nm23/NDPKA and B isoforms: a reflection of their biological function 显示文摘 | Bosnar M H Bago R Cetkovic H | 2009 | Mol Cell Biochem2009，329，12： | 1 |
| 14 | Subcellular localization of A and B Nm23/NDPK subunits显示文摘 | Bosnar MH de Gunzburg J Bago R | 2004 | Exp Cell Res2004，298，1： | 1 |
| 15 | The BNP assay dose not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients Eur显示文摘 | Valle R Bago lin E Canali C | 2006 | Echocardiogr2006，7，1： | 1 |
| 16 | Single-stage treatment with intraoperative ERCP: management of patients with possible choledocholithiasis and gallbladder in situ in a non-tertiary Spanish hospital显示文摘 | L. Rábago I. Chico D. Collado A. Olivares A. Ortega E. Quintanilla M. Delgado J. Castro R. Llorente J. Vazquez Echarri | 2012 | Surgical Endoscopy2012，，4： | 1 |
| 17 | Endoscopic Treatment of Postoperative Fistulas Resistant to Conservative Management Using Biological Fibrin Glue显示文摘 | L. Rábago N. Ventosa J. Castro J. Marco N. Herrera F. Gea | 2002 | Endoscopy2002，，08： | 1 |
| 18 | Two-stage treatment with preoperative endoscopic retrograde cholangiopancreatography (ERCP) compared with single-stage treatment with intraoperative ERCP for patients with symptomatic cholelithiasis with possible choledocholithiasis显示文摘 | L. Rábago C. Vicente F. Soler M. Delgado I. Moral I. Guerra J. Castro E. Quintanilla J. Romeo R. Llorente J. Vázquez Echarri J. Martínez-Veiga F. Gea | 2006 | Endoscopy2006，，08： | 1 |
| 19 | Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients显示文摘AIM: To determine the clinical reasons for conversion to everolimus(EVL) and long-term outcomes in heart transplant(HT) recipients.METHODS: A retrospective 12-mo study has been carried out in 14 Spanish centres to assess the efficacy and safety of conversion to EVL in maintenance HT recipients.RESULTS: Two hundred and twenty-two patients were included(mean age: 53 ± 10.5 years; mean time from HT: 8.1 ± 4.5 years). The most common reasons for conversion were nephrotoxicity(30%), chronic allograft vasculopathy(20%) and neoplasms(17%). The doses and mean levels of EVL at baseline(conversion to EVL) and after one year were 1.3 ± 0.3 and 1.2 ± 0.6 mg/d and 6.4 ± 3.4 and 5.6 ± 2.5 ng/mL, respectively. The percentage of patients receiving calcineurin inhibitors(CNIs) at baseline and on the final visit was 95% and 65%, respectively. The doses and mean levels of CNIs decreased between baseline and month 12 from 142.2 ± 51.6 to 98.0 ± 39.4 mg/d(P < 0.001) and from 126.1 ± 50.9 to 89.2 ± 47.7 ng/mL(P < 0.001), respectively, for cyclosporine, and from 2.9 ± 1.8 to 2.6 ± 1.9 mg/d and from 8.3 ± 4.0 to 6.5 ± 2.7 ng/mL(P = 0.011) for tacrolimus. In the subgroup of patients converted because of nephrotoxicity, creatinine clearance increased from 34.9 ± 10.1 to 40.4 ± 14.4 mL/min(P < 0.001). There were 37 episodes of acute rejection in 24 patients(11%). The most frequent adverse events were oedemas(12%), infections(9%) and gastrointestinal problems(6%). EVL was suspended in 44 patients(20%). Since the database was closed at the end of the study, no further followup data is available.CONCLUSION: Conversion to EVL in maintenance HT recipients allowed minimisation or suspension of the CNIs, with improved kidney function in the patients with nephrotoxicity, after 12 mo. | Nicolás Manito Juan F Delgado María G Crespo-Leiro José María Arizón Javier Segovia Francisco González-Vílchez Sònia Mirabet Ernesto Lage Domingo Pascual-Figal Beatriz Díaz Jesús Palomo Gregorio Rábago Marisa Sanz Teresa Blasco Eulàlia Roig | 2015 | World Journal of Transplantation2015，5，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员